drugset / Trial / NCT03864068
Inositol Supplementation to Treat PCOS (INSUPP-PCOS)
Phase 2
Completed
154 enrolled
Milton S. Hershey Medical Center
National Center for Complementary and Integrative Health (NCCIH) · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
To determine if Inositol, a dietary supplement, will improve ovarian and adrenal androgen excess in women with Polycystic Ovarian Syndrome(PCOS).
Timeline
- Start
- 2020-01-24
- Primary completion
- 2025-12-10
- Completion
- 2025-12-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Inositol | Small molecule | 1 g | — |
| Subject | Inositol | Small molecule | 2 g | — |
| Subject | Inositol | Small molecule | 3 g | — |